Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
نویسندگان
چکیده
منابع مشابه
Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
BACKGROUND Many patients with asthma require frequent rescue medication for acute symptoms despite appropriate controller therapies. Thus, determining the most effective relief regimen is important in the management of more severe asthma. This study's objective was to evaluate whether ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI) provides more effective acute relief of bronchospa...
متن کاملa comparison of teachers and supervisors, with respect to teacher efficacy and reflection
supervisors play an undeniable role in training teachers, before starting their professional experience by preparing them, at the initial years of their teaching by checking their work within the proper framework, and later on during their teaching by assessing their progress. but surprisingly, exploring their attributes, professional demands, and qualifications has remained a neglected theme i...
15 صفحه اولDaclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.
RATIONALE Airway inflammation in asthma is associated with increased activated CD25(+) T cells, IL-2, and soluble IL-2 receptors (IL-2Rs). OBJECTIVES A randomized, double-blinded, placebo-controlled study was used to evaluate the safety and efficacy of daclizumab, a humanized IgG1 monoclonal antibody against the IL-2R alpha chain (CD25) of activated lymphocytes, in adults with moderate to sev...
متن کاملEfficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial.
Increased tumour necrosis factor-α levels have been observed in bronchial biopsies and induced sputum from subjects with severe asthma. We investigated etanercept (ETN) as a therapeutic option for treating moderate-to-severe persistent asthma. In this 12-week, randomised, double-blind, placebo-controlled, phase 2 trial, subjects (n=132) with moderate-to-severe persistent asthma received subcuta...
متن کاملEfficacy/safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
School of Medicine, University of Southampton, Southampton, Hampshire, United Kingdom Allergy Associates Research Center, Portland, Oregon Département des Maladies Respiratoires, Université de la Méditerranée, Marseille, France Department of Medicine, University of Wisconsin, Madison, Wisconsin Department of Respiratory Medicine, University Hospital Gasthuisberg, K.U. Leuven, Leuven, Belgium De...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Pulmonary Medicine
سال: 2016
ISSN: 1471-2466
DOI: 10.1186/s12890-016-0223-3